Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease

References

• Neumeier A, Keith R. Clinical guideline highlights for the hospitalist: the GOLD and NICE guidelines for the management of COPD. J Hosp Med. 2020;15(4):240–241. doi:10.12788/jhm.3368
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Braga L, Salton F, Ruaro B, Confalonieri P. COPD definition: is it time to incorporate also the concept of lung regeneration’s failure? Am J Respir Crit Care Med. 2022;207:1.
   Web of Science ®Google Scholar
• Yang W, Li F, Li C, Meng J, Wang Y. Focus on early COPD: definition and early lung development. Int J Chron Obstruct Pulmon Dis. 2021;16:3217–3228. doi:10.2147/COPD.S338359
   PubMed Web of Science ®Google Scholar
• WHO. Chronic obstructive pulmonary disease (COPD) [EB/OL]; 2021. Available from: https://www.who.int/zh/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease- (copd). Accessed February 8, 2023.
   Google Scholar
• Ennaciri J, Girard D. Immune system: maturation of myeloid cells. Methods Mol Biol. 2009;550:195–203.
   PubMedGoogle Scholar
• Saleh R, Toor SM, Taha RZ, Al-Ali D, Sasidharan Nair V, Elkord E. DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, vista and TGF-beta genes in HLA-DR(-) myeloid cells, compared with HLA-DR(+) antigen-presenting cells. Epigenetics. 2020;15(12):1275–1288. doi:10.1080/15592294.2020.1767373
   PubMed Web of Science ®Google Scholar
• Li J, Zhang X, Liu Q, et al. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice. Cell Immunol. 2018;327:1–12. doi:10.1016/j.cellimm.2017.12.006
   PubMed Web of Science ®Google Scholar
• Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. J Leukoc Biol. 2015;98(6):913–922. doi:10.1189/jlb.4RI0515-204R
   PubMed Web of Science ®Google Scholar
• Salminen A. Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. J Mol Med. 2021;99(1):1–20. doi:10.1007/s00109-020-01988-7
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ma C, Duan Y, et al. Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma. Cancer Discov. 2021;11(5):1248–1267. doi:10.1158/2159-8290.CD-20-0304
   PubMed Web of Science ®Google Scholar
• Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19(2):108–119. doi:10.1038/s41590-017-0022-x
   PubMed Web of Science ®Google Scholar
• Scrimini S, Pons J, Agusti A, et al. Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer. Cancer Immunol Immunother. 2015;64(10):1261–1270. doi:10.1007/s00262-015-1737-x
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA. Immune checkpoints in chronic obstructive pulmonary disease. Eur Respir Rev. 2017;26(144):170045.
   PubMed Web of Science ®Google Scholar
• Narayanapillai SC, Han YH, Song JM, Kebede ME, Upadhyaya P, Kassie F. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis. Carcinogenesis. 2020;41(11):1518–1528. doi:10.1093/carcin/bgaa059
   PubMed Web of Science ®Google Scholar
• Zhao R, Chinai JM, Buhl S, et al. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function. Proc Natl Acad Sci U S A. 2013;110(24):9879–9884. doi:10.1073/pnas.1303524110
   PubMed Web of Science ®Google Scholar
• Dai W, Li Y, Mo S, et al. A robust gene signature for the prediction of early relapse in stage I-III colon cancer. Mol Oncol. 2018;12(4):463–475. doi:10.1002/1878-0261.12175
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883. doi:10.1093/bioinformatics/bts034
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Chen Y, Feng Y, Yan F, Zhao Y, Zhao H, Guo Y. A novel immune-related gene signature to identify the tumor microenvironment and prognose disease among patients with oral squamous cell carcinoma patients using ssGSEA: a bioinformatics and biological validation study. Front Immunol. 2022;13:922195. doi:10.3389/fimmu.2022.922195
   PubMed Web of Science ®Google Scholar
• Xu HH, Wang HL, Xing TJ, Wang XQ. A novel prognostic risk model for cervical cancer based on immune checkpoint HLA-G-driven differentially expressed genes. Front Immunol. 2022;13:851622. doi:10.3389/fimmu.2022.851622
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhao Y, Wu G, et al. Ferroptosis-related lncRNA signature correlates with the prognosis, tumor microenvironment, and therapeutic sensitivity of esophageal squamous cell carcinoma. Oxid Med Cell Longev. 2022;2022:7465880. doi:10.1155/2022/7465880
   PubMed Web of Science ®Google Scholar
• Luyckx A, Schouppe E, Rutgeerts O, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol. 2012;143(1):83–87. doi:10.1016/j.clim.2012.01.011
   PubMed Web of Science ®Google Scholar
• Pan Y, Wang H, An F, et al. CD4(+)CD25(+)CD127(low) regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia. Int Immunopharmacol. 2021;96:107742. doi:10.1016/j.intimp.2021.107742
   PubMed Web of Science ®Google Scholar
• Sharma S, Khosla R, David P, et al. CD4+CD25+CD127(low) regulatory T cells play predominant anti-tumor suppressive role in hepatitis B virus-associated hepatocellular carcinoma. Front Immunol. 2015;6:49. doi:10.3389/fimmu.2015.00049
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu X, Dong H, et al. Bufei yishen formula restores Th17/Treg balance and attenuates chronic obstructive pulmonary disease via activation of the adenosine 2a receptor. Front Pharmacol. 2020;11:1212. doi:10.3389/fphar.2020.01212
   PubMed Web of Science ®Google Scholar
• Glencross DA, Ho TR, Camina N, Hawrylowicz CM, Pfeffer PE. Air pollution and its effects on the immune system. Free Radic Biol Med. 2020;151:56–68. doi:10.1016/j.freeradbiomed.2020.01.179
   PubMed Web of Science ®Google Scholar
• Haist M, Stege H, Grabbe S, Bros M. The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment. Cancers. 2021;13(2):210. doi:10.3390/cancers13020210
   PubMed Web of Science ®Google Scholar
• Huang B, Pan PY, Li Q, et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66(2):1123–1131. doi:10.1158/0008-5472.CAN-05-1299
   PubMed Web of Science ®Google Scholar
• Sun L, Wang X, Saredy J, Yuan Z, Yang X, Wang H. Innate-adaptive immunity interplay and redox regulation in immune response. Redox Biol. 2020;37:101759. doi:10.1016/j.redox.2020.101759
   PubMed Web of Science ®Google Scholar
• Rieder SA, Wang J, White N, et al. B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling. Cell Mol Immunol. 2021;18(6):1503–1511. doi:10.1038/s41423-020-0361-7
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yao S, Iliopoulou BP, et al. B7-H5 costimulates human T cells via CD28H. Nat Commun. 2013;4:2043. doi:10.1038/ncomms3043
   PubMed Web of Science ®Google Scholar
• Corzo CA, Cotter MJ, Cheng P, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol. 2009;182(9):5693–5701. doi:10.4049/jimmunol.0900092
   PubMed Web of Science ®Google Scholar
• Raber PL, Thevenot P, Sierra R, et al. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer. 2014;134(12):2853–2864.
   PubMed Web of Science ®Google Scholar
• Kumar V, Donthireddy L, Marvel D, et al. Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell. 2017;32(5):654–668 e655. doi:10.1016/j.ccell.2017.10.005
   PubMed Web of Science ®Google Scholar
• Yang Z, Guo J, Weng L, Tang W, Jin S, Ma W. Myeloid-derived suppressor cells-new and exciting players in lung cancer. J Hematol Oncol. 2020;13(1):10. doi:10.1186/s13045-020-0843-1
   PubMed Web of Science ®Google Scholar
• Kalathil SG, Lugade AA, Pradhan V, et al. T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;190(1):40–50. doi:10.1164/rccm.201312-2293OC
   PubMed Web of Science ®Google Scholar